To further confirm the role of SNHG16 in the involvement of CVDs, we determined the expression levels of SNHG16, miR‐205 and Smad2 in the plasma samples from healthy volunteers and patients with atherosclerosis. This evidence concerns the gene SMAD2 and atherosclerosis.